Welcome to Bristol Myers Squibb California
Bristol Myers Squibb’s robust and growing presence in California is transforming the way cancer and other difficult-to-treat diseases are approached.
Scientists and researchers with diverse backgrounds and expertise in San Diego, Redwood City, Brisbane and San Francisco collaborate across teams, functions and sites to follow their own scientific curiosity, enabling fast, flexible science that ultimately increases the efficiency and success of drugs in the clinic. These efforts, at a time when the pace of technological advancements and creation of new biomedical knowledge is accelerating, are laying the foundation for investigational molecules that may one day have a significant therapeutic impact.
Meet our team
Learn about our leaders who are making a difference in California.
Miranda Broz, Ph.D., serves on a team responsible for exploring parts of the tumor microenvironment (TME) to better uncover how a tumor functions, with the hope of eventually turning these findings into novel treatment options that will benefit patients with difficult-to-treat cancers.
Join us as we transform patient lives through science
Every day, each of us work to improve outcomes of patients fighting serious diseases. Together we’re building a better future for each other and the patients who need us the most.
Driving innovation forward in California
Learn about our broad scope of scientific innovation in California.
As a scientific research community, our work is never done for cancer patients. Building upon established science allows researchers to pursue new approaches, test new hypotheses and – ultimately – uncover new answers to emerging and enduring questions that may address unmet needs for patients.
Community impact
Learn about how we are making a difference in communities across California
University of California San Francisco will create an in-person and virtual-based patient navigation program to enhance the quality of cancer care for English, Chinese, and Vietnamese patients newly diagnosed with colorectal, liver, or lung cancer in the Greater San Francisco Bay Area.
The CFCCC will build a formal collaborative network as a hub/spoke model between community organizations, CalOptima primary and specialty care providers, and UCI’s specialists to provide more efficient and effective cancer care for low income MediCal Vietnamese, Korean, and Chinese patients in Orange County, California.
University of California Davis, in a collaborative partnership with the Health and Life Organization, will prospectively identify and follow Asian American patients across the cancer continuum to improve cancer prevention and control behaviors to create a New Patient Referral service between a federally qualified healthcare center lookalike and National Cancer Institute Comprehensive Cancer Center.
Additional resources
Learn more about our scientific approaches and innovation.